Edwards Lifesciences News and Activities

Presence

Edwards Lifesciences develops medical technologies for structural heart disease and critical care. Its main products include heart valve systems, monitoring devices, and related services for hospitals, physicians, and patients.

Edwards Lifesciences products and services overview:

Heart valve devices
Critical care monitoring
Surgical therapies
Transcatheter therapies
Patient monitoring systems

Revenue: ~$5 billion

Employees: 15,000

Headquarters: Irvine, United States (USA)

Edwards Lifesciences is one of the...

Edwards Lifesciences is a company listed under the stock ticker EW (US).

Edwards Lifesciences has a direct presence in 5 countries.

Edwards Lifesciences has 6 subsidiaries including Edwards Lifesciences Australia, Edwards Lifesciences India and Edwards Lifesciences Japan.

They are in:

Biotechnology86%
Medical Equipment14%

Acquisition, funding and merger involving Edwards Lifesciences.

Edwards Lifesciences has announced the acquisition of JenaValve Technology (posted on July 26 2024).

Executives

View the org chart displaying its 71 main executives

Most searched biographies at Edwards Lifesciences

Popular executive movements at Edwards Lifesciences

Scott Ullem, Corporate Vice President and Chief Financial Officer, will leave the company in Oct. 2026 (posted on May 5 2026).
Doretta Mistras has joined the company as Corporate Vice President and Chief Financial Officer (posted on May 5 2026).
Amit Agarwal has joined the company as Senior Vice President, Transcatheter Edge-to-Edge Repair Therapies (posted on February 24 2026).

Click here to view some more movements at Edwards Lifesciences

Create your alert
to follow the executive moves at Edwards Lifesciences.